Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Clinical trial NCT04339140 · COMPLETED
Trial details
- NCT number
- NCT04339140
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2023-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.